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The RPC developed a new phantom to ensure comparable and consistent radiation 
administration in spinal radiosurgery clinical trials.  This study assessed the phantom’s 
dosimetric and anatomic utility. The ‘spine phantom’ is a water filled thorax with 
anatomy encountered in spinal radiosurgery: target volume, vertebral column, spinal 
canal, esophagus, heart, and lungs.  The dose to the target volume was measured with 
axial and sagittal planes of radiochromic film and thermoluminescent dosimeters (TLD).  
The dose distributions were measured with the radiochromic film calibrated to the 
absolute dose measured by the TLD.  Four irradiations were administered: a four angle 
box plan, a seven angle conformal plan, a seven angle IMRT plan, and a nine angle 
IMRT plan (denoted as IMRT plan #1 and plan #2, respectively).  In each plan, at least 
95% of the defined tumor volume received 8 Gy.  For each irradiation the planned and 
administered dose distributions were registered via pinpricks, and compared using point 
dose measurements, dose profiles, isodose distributions, and gamma analyses. Based on 
previous experience at the RPC, a gamma analysis was considering passing if greater 
than 95% of pixels passed the criteria of 5% dose difference and 3 mm distance-to-
agreement.  Each irradiation showed acceptable agreement in the qualitative assessments 
and exceeded the 95% passing rate at the 5% / 3 mm criteria, except IMRT plan #1, 
which was determined to have been poorly localized during treatment administration. The 
measured and planned dose distributions demonstrated acceptable agreement at the 5% / 
 v 
3mm criteria, and the spine phantom was determined to be a useful tool for the remote 
assessment of an institution’s treatment planning and dose delivery regimen. 
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Chapter 1 Introduction 
1.1 Spinal Metastases and Radiation Therapy 
The spine is the most common site for bony metastases. An estimated 40% of cancer 
patients develop spinal metastases, and approximately 10-20% of these patients suffer 
symptomatic spinal cord compression from these lesions.  This amounts to more than 25,000 
cases per year. Approximately 70% of spinal tumors originate from a primary tumor 
elsewhere in the body, the majority from primary cancers of the lung, breast, and prostate.  
Lesions can also originate in the spine; these include meningiomas, schwannomas, osseus 
tumors, and gliomas.  Spinal cord compression often presents with back pain, instability, and 
neurologic deficit (Klimo 2004).   
Management of spinal tumors includes radiation, surgery, and chemotherapy.  The 
role of radiation has evolved with developments in diagnostic imaging, inverse treatment 
planning, image-guided therapy, and intensity modulated radiation therapy (IMRT).  As more 
institutions across the country are able to deliver highly conformal doses with smaller 
margins of error, hypo-fractionated and single-fraction treatments for spinal tumors show 
increasing promise as a new standard of care.  This type of approach, when applied to the 
head and spine, falls under the banner of ‘sterotactic radiosurgery’ (SRS).  This term, coined 
by Lars Leksell in the 1950’s, was based on combining an intracranial guidance device and 
an orthovoltage X-ray unit. Since then, the term has come to encompass techniques for 
delivering a high dose of radiation in a small number of fractions (< 5) with a high degree of 
spatial accuracy  using image guidance and immobilization (Dodd 2008).  In the literature, 
spinal radiosurgery is often categorized under SRS or under stereotactic body radiotherapy 
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(SBRT).  In this paper, radiation delivered to spinal tumors in a single fraction with image 
guidance and immobilization will be referred to as spinal radiosurgery.    
A previous Radiation Therapy Oncology Group (RTOG) trial established that a single 
dose of 8 Gy accomplished the same degree of pain relief as 10 fractions of 3 Gy (a total 
dose of 30 Gy) (RTOG 2009). However, these results were based on conventional 
administration of radiation (non-IMRT).  The optimum dose level using ‘dose-painting’ 
techniques  for spinal metastases is actively under investigation (RTOG 2009). Ryu et al. 
treated patients with image-guided radiosurgery on a BrainLAB (Westchester, IL) Novalis® 
system (treatments were intensity modulated with a micro MLC); these patients received 
single fraction doses of 10 to 16 Gy, and achieved an overall pain control rate for one year of 
84% (Ryu 2008). Gerszten et al. described the success they had with single fraction dose, 
delivered on an Accuray (Sunnyvale, CA) Cyberknife® system (a cylindrically collimated 
linac on an articulating robotic arm), from 12.5 to 25 Gy; 290 of their 336 cases achieved 
long term pain improvement (Gerszten 2007).  Chang et al. treated 74 patients with 
metastatic spinal lesions with IMRT and near simultaneous CT guidance; these patients 
received 6 Gy in 5 fractions, later amended to 9 Gy in 3 fractions.  Chang et al. reported 84% 
progression free incidence after 1 year (Chang 2007).  These studies described the benefit 
achieved at escalated dose levels; however, there has been a dearth of prospective studies on 
the benefit of an escalated prescription level.  This dearth is being addressed by the Radiation 
Therapy Oncology Group (RTOG).  The RTOG is currently enrolling patients into protocol 
0631, a phase II/III study of image-guided radiosurgery/stereotactic body radiotherapy for 
localized spine metastases.  This protocol randomizes patients into two arms. The first arm 
treats patients with an escalated dose level in a single fraction (16 Gy) delivered via ‘dose-
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painting’ techniques (such as IMRT); the second arm uses a single fraction at a lower dose 
level (8 Gy) delivered conventionally (non-IMRT).  Both arms of the protocol require image 
guidance and immobilization in order to ensure treatment accuracy (RTOG 2009).  
 
1.2 The Radiological Physics Center and Remote Quality Assurance 
The Radiological Physics Center’s (RPC) mission is “to assure NCI and the 
Cooperative Groups that institutions participating in clinical trials deliver prescribed 
radiation doses that are clinically comparable and consistent.” 
 The RPC accomplishes this mission in several ways: machine output checks with 
mailed TLD, dose algorithm checks on reference patients, quality assurance procedure 
reviews, on-site dosimetry review visits, credentialing for participation in clinical trials, and 
retrospective reviews of an institution’s treatment records.  The RPC also utilizes 
anthropomorphic phantoms for remote quality assurance. The RPC employs head and neck, 
thorax, and pelvic phantoms, among others.  Typically, the phantoms are water-filled and 
contain materials of different densities in simple geometries to model the anatomy of interest. 
Dosimetry is accomplished using film and thermoluminescent dosimeters (TLD) loaded into 
the organs-at-risk and the treatment volumes.  The phantoms are mailed to institutions 
participating in clinical protocols. The institution irradiates the phantom according to their 
treatment plan and procedures, and sends the phantom back to the RPC.  The RPC then 
assesses the delivered dose (measured via the radiochromic film and TLD) to ensure it 
conforms both to the prescribed treatment plan and to standards set forth by a given protocol.  
This process enables the RPC to verify an institution’s entire treatment process: imaging, 
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planning, dose calculation, positioning, and dose delivery, before treatments are administered 
to patients.  
The RTOG Protocol 0631 falls under the RPC’s purview.  The RPC designed a new 
phantom to address this new clinical protocol.  The materials, anatomical layout and dose 
measurement geometry of this new phantom are described more fully in the Methods and 
Materials section.  Essentially, the new phantom, denoted herein as the ‘spine phantom’, is a 
water-filled anthropomorphic chest with low-density lungs and a spine insert that simulates 
the spinal cord, vertebral column, esophagus, and target volume.     
 However, the utility of this newly designed and manufactured spine phantom has to 
be verified before it can be used as a dosimetry tool by the RPC.  This work tested the utility 
of the spine phantom.  Both the anatomic utility and dosimetric utility were assessed.  The 
planning utility concerned how well the spine phantom represented the challenges of 
planning spinal irradiations in the layout and proportion of the organs-at-risk and target 
volumes.  The dosimetric utility concerned whether TLD and radiochromic film recovered 
from the phantom consistently measured the administered dose.  Establishing the dosimetric 
utility was accomplished through the administration of radiation treatment plans of varying 
complexity, and assessing how well the results, measured via radiochromic film and TLD, 
agreed with the planned dose distribution.   
 
1.3 Dosimeters 
 The remote dosimetry system utilized by the RPC is a combination of radiochromic 
film and thermoluminescent dosimeter (TLD).  The radiochromic film used is this project 
was Gafchromic EBT film, manufactured by International Specialty Products (Columbia, 
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MD).  The optical density (OD) of the radiochromic film increases as a function of dose, and 
does not require development.  The film was used to measure relative dose distributions.  The 
TLD measured an absolute dose to a small volume, to which the relative dose distribution 
was calibrated. The system is discussed in more detail in Methods and Materials section. 
 
1.4 Hypothesis and Specific Aims 
Hypothesis: 
The newly constructed spine phantom provides a useful model for planning intensity 
modulated radiosurgery for spinal tumors, and the collapsed-cone convolution dose 
algorithm accurately models the dose distributions measured via radiochromic film and TLD. 
This hypothesis was tested by the following specific aims: 
Specific Aims: 
1. Qualitatively assess the anatomic layout of the spine phantom and how well it 
models anatomical features of a patient of similar chest breadth. 
2. Develop treatment plans that do not use intensity modulation to irradiate the 
treatment volume to the relevant prescription dose. 
3. Develop intensity-modulated treatment plans with clinically relevant prescription 
dose to the planned tumor volume and clinically relevant dose constraints on the 
organs at risk. 
4. Compare the planned and measured dose distributions with quantitative and  
qualitative assessments: point dose, dose profiles, and isodose distributions. 
5. Compare the planned and measured dose distributions using a gamma analysis
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Chapter 2 Methods and Materials 
2.1 The Spine Phantom 
2.1.1 Schematic and Materials 
The spine phantom has overall dimensions of 40 cm width by 30 cm height by 30 cm 
length. The outer shell is a 6 mm thick shell of polyvinyl chloride.  Inside the shell, a nylon 
sphere serves as the heart.  The left lung is a removable cylindrical compressed cork insert 
with a tumor feature; this phantom also serves as a remote quality assurance tool for lung 
protocols.  The right lung is permanent, and is also made of compressed cork.  A large hole 
with a sealing screw cap is located on the superior end of the phantom for water filling.  Any 
portion of the inner cavity of the shell not occupied by anatomy fills with water; this serves 
the dual purpose of near tissue equivalence and provides ease of handling the unfilled 
phantom.  These features are illustrated in Figure 2.1.  
 
  
 
 7 
 
Anatomy: Material Density (g/cm3) 
Heart Nylon 1.06 
Tumor Acrylic 1.07 
Spine Polystyrene 1.2 
Spinal Canal Solid Water 1.03 
Lung Cork 0.3 
 
Figure 2.1:  An illustration of the spinal phantom with mid-axial and mid-sagittal views from 
CT imaging.  The anatomical features are labeled and the materials and densities listed in 
the table above.  
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Figure 2.2:  A schematic of the axial isocenter plane of the spinal insert.  The crosses denote 
the pin-prick locations used for localization.   
 
The spine insert was designed and built at the RPC based on the anatomy of sample 
patients selected as representative cases for spinal radiosurgery. The spinal insert, highlighted 
in Figure 2.1, is loaded inferiorly into the spine phantom, and has dimensions of 30 cm by 10 
cm by 4 cm. The insert runs the length of the phantom, between the posterior portions of the 
lungs.  When inserted, the insert locks into place with screws for reproducible placement.  
The insert contains pertinent anatomy for spinal irradiations: spinal cord, esophagus, 
vertebral column, and a target volume, the anatomical features are shown in Figure 2.2.  The 
materials chosen for these anatomical features roughly correspond to anatomical densities, 
and are detailed in section 3.2.  The different materials provide CT contrast for ease of 
anatomical contouring.  
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2.1.2 Dose Measurement in the Spinal Insert 
The spinal insert, when removed, disassembles into a superior and inferior portion, 
depicted in the Figure 2.3. The disassembled portions of the spinal insert bisect the acrylic 
tumor volume.   
 
 
Figure 2.3:  A photograph of the removed spinal insert.  To illustrate the relative location of 
the film planes, radiochromic film was placed on the sagittal and axial planes of the 
disassembled insert.  Also, the different materials used in the construction of the anatomy of 
interest are visible. 
 
The radiochromic film was cut exactly to the axial dimensions of the spinal insert.  
Three pins are embedded in the axial face of the dissembled spinal insert.  When placed onto 
the axial plane of the spinal insert, the radiochromic film is pierced by the pins, registering 
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the axial film slice to the fixed geometry of the pins.  For the sagittal dose plane, slices were 
machined into the spine insert, creating a thin sagittal plane bisecting the tumor volume.  
Radiochromic film was inserted into these cuts for sagittal dose distribution measurement.  
Once inserted, the sagittal film slices can be registered with pinpricks through holes that 
traverse the spine insert, perpendicular to the sagittal film plane.  The pin-pricks on the film 
correspond to the known geometry of the holes for registration.   
Figure 2.4 shows the relation of the axial and sagittal film planes in the spine insert 
and the relative location of the TLD capsules.  The varied spatial position of the TLD 
capsules within the target volume provided measurements of absolute dose at various depths. 
 
Figure 2.4: An illustration of the sagittal and axial film slices (the axes of the TLD capsules 
run parallel to the sagittal film); each TLD capsule is located within the PTV, and their 
locations relative to the target volume center are labeled. 
 
The radiochromic film utilized in this project, Gafchromic EBT, has properties that 
make it ideal for use in remote quality assurance applications.  The film requires no 
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development, and can be cut to any shape required by the dimensions of the film plane.  The 
film is insensitive to visible light, allowing for ease of use and portability.  The radiochromic 
film has a high spatial resolution allowing for the measurement of the steep dose gradients 
used in spinal radiosurgery.  The film can also be calibrated over a clinically useful range of 
doses (up to 10 Gy), is water equivalent, and the response is independent of energy and dose 
rate.  Fuss et al. also found the film response independent of beam quality by irradiating the 
film at different depths.  This characteristic is particularly useful, as calibration of the film 
need not be conducted at the depth at which it is placed in the phantom. The main caveat for 
use of Gafchromic EBT film is that it continually develops; thus, it is not well suited to 
permanent storage of dose data (Fuss 2007). 
The film was cut to the required size and shape for the spine phantom.  The following 
schematics in Figures 2.5 and 2.6 show the size of the films utilized and the locations of 
registration markings: 
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Figure 2.5:  Schematic of the axial film slice.  All measurements are in millimeters.  The 
crosses denote the position of the registration pin locations.   
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Figure 2.6:  Schematic of the sagittal film slice.  All measurements are in millimeters.  The 
crosses denote the position of the registration pin locations.   
 
2.2 Qualitative Assessment of the Planning Utility of the Spine Phantom 
The spine phantom will serve the purpose of assessing an institution’s ability to 
image, develop a treatment plan, and deliver the stereotactic plan.  An important component 
of the utility of the phantom in this assessment is that it presents a reasonable simulation of 
spinal anatomy.  Granted, there is no one ‘correct’ anatomy for a spine and spine tumor; 
spinal tumors vary greatly in size and presentation.  Tumors may involve multiple levels, 
range greatly in mass, and proximity to the spine.  However, it is still critical that the design 
of the spine phantom be representative in a few categories: depth, size, and proximity to the 
spinal cord. 
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To assess how well the spine phantom conforms to these criteria, CT scans for a 
patient with comparable chest breadth to the spine phantom were acquired, and 
measurements were taken of pertinent critical anatomy.  This process allowed for a 
reasonable qualitative assessment of the anatomic utility of the spine phantom. 
 
2.3 Phantom Simulation and Treatment Planning   
2.3.1 Simulation 
The phantom was simulated on a Philips AcQsim CT scanner.  Prior to scanning, film 
and TLD were loaded into the phantom.  The phantom was filled with water, with care taken 
to avoid air bubbles (the design of the phantom, with a sloping chest, prevented air bubbles 
from being near the treatment fields).  The following parameters were used in the acquisition: 
120 kVp, dynamic mAs, and 1.5 mm slice thickness.  The simulation system allowed for 
landmarking of the target isocenter during the simulation.  Once landmarked, the CT couch 
then shifted the room lasers for external marking of the simulation isocenter.  Three plastic 
fiducials were used to mark the laser positioning for an approximate treatment setup.  
 
2.3.2 Treatment Planning System 
The Philips “Pinnacle” treatment planning system (TPS), version 7.6, was utilized for 
the design of each treatment plan administered to the spine phantom.  This TPS utilized a set 
of M.D. Anderson’s standard institutional beam data for the Varian 2100 linear accelerators.  
These beam data are the clinical standard at M.D. Anderson.  For IMRT planning, the TPS 
employed an inverse planning algorithm; for a given beam arrangement and set of dose 
parameters, the TPS calculated the optimal step-and-shoot MLC fields and the monitor units 
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for each field.  The planning process involved the incremental optimization of a plan until it 
is clinically acceptable. 
Pinnacle 7.6 was also utilized for the forward-planning process of a set of simple-
beam arrangements plans.  In this planning process, the field shapes, beam arrangements, and 
beam weighting were set by the user; the TPS then calculated the necessary monitor units to 
irradiate the target volume to the prescription dose.  
The planned dose was calculated with the collapsed-cone convolution algorithm 
implemented in Pinnacle.  This dose algorithm is the clinical standard at M.D. Anderson.  
The algorithm addressed the heterogeneity in the phantom (it does not assume a uniform 
density of water, but calculated dose based on the CT number of the scanned phantom). 
Addressing heterogeneity is important in the spine phantom because, depending on the beam 
arrangement, a significant portion of the beam passes through high density simulated bone 
material and low density simulated lung material.   
 
2.3.3 Forward Treatment Planning 
Four different treatment plans were developed for the spine phantom. In each plan, a 
prescription dose level of 8 Gy was utilized.  This dose level is not at the prescription level 
delineated in the RTOG 0631 protocol (which escalates the dose to 16 Gy). This lower dose 
level was chosen to keep the prescription within the dosimetric range of the radiochromic 
film.   
First, a four beam plan was created; beams were placed anteriorly, posteriorly, left, 
and right (IEC convention: 0°, 180°, 270°, and 90°).  The planning target volume (PTV) was 
the acrylic tumor contour expanded by 1 mm. A dose of 8 Gy was prescribed to 95% of the 
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PTV with equal beam weighting.  This plan will be referred to herein as the four-field box 
plan.   
Next, a conformal plan was developed.  Seven beams were arranged posteriorly (90°, 
120°, 150°, 180°, 210°, 240°, and 270°).  The acrylic tumor contour was expanded 1 mm. 
The plan was conformal; each beam was collimated with the multi-leaf collimator to the 
planning target volume.  8 Gy was prescribed to 95% of the PTV.  This plan will be referred 
to herein as the conformal plan. 
The four-field box and conformal plans had no intensity modulation.  These plans 
were developed to help establish the baseline agreement between planned and measured 
dose.  Venselaar et al. demonstrated that, for simple beam geometries with larger field sizes, 
the accuracy of the treatment planning calculation was greater (Venselaar 2001).  These plans 
had less clinical significance because they ignored spinal cord dose constraints in favor of 
simplicity in design, ease of administration, and measurement accuracy. 
 
2.3.4 Inverse Treatment Planning for IMRT 
Next, two intensity modulated plans were developed.  Two different beam 
arrangements were utilized; one borrowed from the treatment plan for a patient at M.D. 
Anderson, the other with a beam arrangement optimized for the irradiation of spinal 
metastases (Pugachev 2001).  The dose constraints for the anatomy of interest were taken 
from the RTOG protocol 0631 (RTOG 2009).  The pertinent constraints from the protocol 
are listed in Table 2.1. 
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Critical Structures and 
Dose Constraints Critical Volume 
Max. Dose to Critical 
Volume 
Max. Point Dose To 
Critical Volume 
Spinal Cord 10% / 3% 3.5 Gy / 5 Gy 7 Gy 
Esophagus 15% 6 Gy 8 Gy 
Lungs 20% 3.7 Gy  
 
Table 2.1: The critical structures and the dose/volume constraints for each delineated by the 
RTOG protocol 0631. 
 
In Philips’ Pinnacle treatment planning software, the dose constraints for the critical 
structures were entered into the inverse treatment planning software.  Each dose constraint 
was assigned a weighting factor. In spinal radiosurgery, the spinal cord is the limiting factor 
for higher levels of dose to the target volume, due to its proximity (in the spine phantom, the 
spinal cord is 7 mm posterior to the target volume) and the devastating nature of radiation 
induced myelopathy (Dodd 2008). 
With the beams arranged and the dose constraints assigned, the TPS optimized the 
modulated, step-and-shoot MLC fields for achieving the specified dose distribution.  Once 
the software created the plan, the dose distribution and dose-volume histograms were 
assessed.  Then, the weightings were adjusted, and the plan re-optimized.  This iteration 
continued until the resultant plan satisfied the user’s criteria (Holder 2004).   
Two IMRT plans were developed, the dose distributions are shown in Figure 2.9 and 
2.10.  The first plan did not satisfy the clinical constraints; however, this plan still yielded 
insight into how well the internal dose-measurement system agreed with the calculated dose 
distribution.  The second plan satisfied the clinical constraints set forth by the protocol.  This 
plan was the type of plan that may be administered by institutions participating in the 
protocol. 
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The first IMRT plan utilized 6 MV photons and seven fields; the beam angles were 
100°, 120°, 150°, 180°, 200°, 230°, and 260°.  This plan will be referred to herein as IMRT 
plan #1. 
The second IMRT plan also utilized 6 MV photons, but used nine fields; the beam 
angles 60°, 105°, 130°, 150°, 165°, 180°, 210°, 230°, and 280°. This plan will be referred to 
herein as IMRT plan #2. 
 
2.4 The Treatment Plans 
 The following images in Figures 2.7-2.10 show the dose distributions on the axial CT 
slices of the spine phantom at isocenter.  The beam arrangement and number of monitor units 
per field are listed below the dose distribution image.  The prescription dose for each plan 
was 8 Gy to at least 95% of the volume of the PTV. 
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Four-Field Box:     
Beam # 1 2 3 4 
Gantry Angle: 0 270 180 90 
MU’s: 343 343 343 343 
 
 
Figure 2.7: The dose distribution for the four-field box plan; the gantry angles and numbers 
of monitor units per field are shown.  Below the table are the dose volume histograms for the 
critical structures. 
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Conformal:        
 Beam # 1 2 3 4 5 6 7 
Gantry Angle: 270 240 210 180 150 120 90 
MU’s: 197 197 197 197 197 197 197 
 
 
Figure 2.8: The dose distribution for the conformal plan; the gantry angles and number of 
monitor units per field are shown. Below the table are the dose volume histograms for the 
critical structures.
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Figure 2.9: The dose distribution for the IMRT plan #1; the gantry angles and numbers of 
monitor units per field are shown. Below the table are the dose volume histograms for the 
critical structures. 
 
IMRT #1:         
Beam #: 1 2 3 4 5 6 7 
Gantry Angle: 260 230 200 180 150 120 100 
MU’s: 302 429 340 376 187 461 551 
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IMRT #2:           
Beam #: 1 2 3 4 5 6 7 8 9 
Gantry Angle: 280 230 210 180 165 150 130 105 60 
MU’s 310 366 314 322 485 321 414 266 365 
 
 
Figure 2.10: The dose distribution for the IMRT plan #2; the gantry angles and numbers of 
monitor units per field are shown. Below the table are the dose volume histograms for the 
critical structures.
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IMRT plan #2 met the constraints set forth by the RTOG 0631 protocol.  The 
cumulative dose-volume histogram of the spinal cord was compared to the average DVH 
from a study conducted by Ryu et al. Figure 2.11 plots the DVH of IMRT plan #2 along 
with the average spinal cord DVH for 50 patients from Ryu’s study.  The comparison is 
appropriate, as the partial cord volume was defined the same for Ryu’s patients and for 
the IMRT plan #2 treatment. 
 
 
Figure 2.11: A comparison of the partial cord DVH from the treatment plan utilized in 
this study and the average DVH across 50 patients measured by Ryu et al. 
 
The graph demonstrates that IMRT plan #2 achieved a dose-volume histogram for the 
spinal cord that satisfies the requirements of the protocol, and has a lower cord dose at all 
fractions of the partial cord volume when compared to clinical findings (Slotman 2006).  
The DVH for the spinal cord may be significantly lower than that of the Ryu et al. study 
because of the 7 mm gap between the spinal cord and the target volume (it is more than 
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twice the minimal proximity in RTOG 0631, 3 mm, under which patients are excluded); 
the spine phantom may represent a relatively easy planning challenge to institutions 
participating in RTOG 0631.  
 
2.5 Stereotactic Positioning 
In radiosurgery, positioning must be accurate with a high level of confidence.  
The RTOG protocol 0631 calls for 0-3 mm margins around the PTV.  For these plans, the 
margin used was 1 mm.  Image guidance is a prerequisite for entry into RTOG Protocol 
0631.  Participating institutions approach radiosurgery with a variety of positioning 
solutions.  Typically, these involve the use of orthogonal kV imaging, followed by table 
shifts and position checks.  Other approaches include cone-beam CT or CT on rails.  The 
common theme is the utilization of imaging of anatomical structures at the time of 
treatment (Chen 2009). 
The rigidity of the phantom negated part of the positioning problem, as 
positioning is not compromised once the phantom is in place.  This rigidity obviates the 
use of stabilization devices used in radiosurgery, such as the Elekta (Stockholm, Sweden) 
BodyFIX® system. 
For the irradiations conducted in this study, an alternate approach to image guided 
positioning was devised to ensure accuracy.  First, the location of the treatment isocenter, 
noted from the TPS, was marked on a set of sagittal and axial radiochromic films.  These 
films were then loaded into the spinal insert, and the spinal insert was loaded into the 
phantom.  The phantom was set to an initial position according to external fiducials 
placed during simulation on the patient support table.  Then, a series of irradiations were 
  
 
 25 
administered with the collimator jaws set to a 1 mm gap.  The gantry and collimator 
angles were varied at 90° increments, creating a cross pattern on the radiochromic film.  
The spinal insert was removed, and a shift was calculated between the machine isocenter 
(the center of the cross pattern) and the treatment isocenter (marked on the film), and this 
shift was applied to the patient support table.  This process was iterated until there was 
exact coincidence between the machine and treatment isocenters.  An image of an 
iteration of this process is shown in Figure 2.12. 
This procedure is analogous to a hidden target test, described in AAPM TG-42.  
In these types of tests, a lead or steel bearing is located at the treatment isocenter, and 
deviations from the machine isocenter are measured (Schell 1995).  In the localization 
technique for the spine phantom described above, these deviations were measured, and 
then corrected for with a patient support table shift. 
 
 
Figure 2.12: Sample image of the radiochromic film used for localization of the 
treatment isocenter to the machine isocenter. For the 1 mm wide fields, a 1.5 mm wide 
region developed on the film. After each irradiation, the shift was calculated and applied; 
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this process was iterated until the treatment isocenter coincided with the machine 
isocenter.  
 
This approach provided accurate positioning of the treatment isocenter to the 
machine isocenter.  Although institutions being credentialed cannot use this process for 
positioning, the goal of this project was to assess the agreement of the planned dose 
distribution to the measured dose distribution; error introduced by positioning uncertainty 
from image guidance may have confounded the results. This localization procedure 
bypassed the positioning uncertainty introduced by image guided positioning. 
 
2.6 Treatment Administration 
Once in position, the phantom was ready for treatment.  The spinal insert was 
loaded with film and TLD, and the MLC fields were loaded into the controller.  After 
checking the clearance of the linear accelerator around the spine phantom, the treatment 
started.  In order to bypass the record and verify system, the plans were delivered 
manually.  Since the treatment administration was manual, the gantry angle, collimator 
angle, number of monitor units, and dynamic MLC file had to be loaded for each beam.  
No safety interlocks prevented administration of the wrong field at the wrong angle, so a 
double-tiered checklist was utilized to prevent error.   
Each treatment plan was administered three times.  Between each trial, the spine 
insert was removed, and new TLD and film were placed in the insert.  A long pin was 
used to pierce the film for registration in the sagittal aspect. The phantom was not re-
positioned between trials.  
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2.7 Data Collection and Processing 
The RPC has a long history using TLD for dosimetry; it has been an essential 
component of the remote quality assurance regimen for 30 years.  Since 1996, TLDs have 
been implemented in anthropomorphic phantoms.  Kirby et al. described the uncertainties 
in a powder TLD system, and ascribed a +/-5% action criterion for TLD checks, 
corresponding to a 93% confidence interval (Kirby 1992). 
TLD-100, manufactured by the Radiation Detection Company in Gilroy, CA, was 
utilized in these experiments.  The TLD powder is placed in custom made cylindrical 
capsule measuring 15 mm in length and 4 mm in diameter. The wall thickness of the 
capsule is 1 mm.  Each capsule contained approximately 40 mg of TLD powder. The 
TLD capsules utilized were ‘double loaded’; each capsule contained two discrete aliquots 
(allowing for more measurement points).  The volume of each of these aliquots is 
approximately 13 mm3. 
 
2.7.1 TLD Dose Calculation 
The following formalism is utilized by the RPC for the calculation of dose from 
the thermoluminescent response of the TLD (Davidson 2006). 
 
 efl KKKSTLD ****=  
 
D:  Absorbed dose to muscle 
TL:  Mean thermoluminescent response per unit mass 
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S:  Sensitivity or absorbed dose per thermoluminescent response for standards 
irradiated with 60Co 
Kl:  Linearity correction 
Kf : Fading correction 
Ke: Correction to energy used to irradiate (6 MV) 
  
Determination of S: 
The sensitivity, S, was determined during each TLD readout session, and corrects 
for variations of the reflectivity of the planchette, optics, and electronics.  First, TLD 
known as ‘high dose standards,’ were irradiated in 60Co to approximately 20 Gy.  Six 
high dose standards were read, three at the beginning of the session, three at the end of 
the session.  The following equation was used to calculate S for the session: 
  
sfl
s
TKK
D
S
!
=
*  
Ds: Expected dose to TLD (decay corrected ion chamber measurement) 
Ts: mean thermoluminescent response for the high dose standards per unit 
mass 
Kl:  Linearity correction 
Kf : Fading correction 
 
Determination of Kl: 
The linearity correction, Kl, corrected the supra-linearity of the 
thermoluminescent response (TL).  For a batch of TLD (in this case, ‘B07’), capsules 
were irradiated to ten dose levels, varying from 3-50 Gy.  Three capsules were averaged 
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at each dose level.  This mean TL signal was then corrected for sensitivity and fading, 
and normalized to the TL signal at the 3 Gy level.  This normalized dose response was 
then plotted against the relative signal.  The inverse of this plot was calculated and fit 
with a second order polynomial.  This resultant relationship follows: 
 
cbDaDK
lll
++=
2
 
a = 2.290E-08 
b = -2.12E-04 
c = 1.06 
Dl = TL · S · Kf · Ke 
 
Determination of Kf: 
The TL response is dependent upon the time elapsed between the irradiation of 
TLD and the readout.  To correct for dependence, the fading of a batch B07 was 
characterized with a double exponential: 
 
DdBdf CeAe
N
K
!!
+
=
 
 
d  = number of days elapsed between irradiation and readout 
N = 1.35 
A = 1.28 
B = 1.08E-4 
C = 0.068 
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D = 0.072 
 
Determination of Ke: 
The energy correction was calculated as the ratio of the response of TLD for 60Co 
energy to the response of TLD at the energy of interest; for these trials, the energy 
utilized was 6 MV.  The correction applied for TLD irradiated at this energy was 1.03. 
The TLD from each phantom irradiation trial were read by RPC staff members.  
The results from the reading session include TL reading from controls and high dose 
standards used to calculate the system sensitivity; dates and times for irradiations are also 
included for fading corrections.  These data were used in a TLD dose calculation 
spreadsheet which iterated the solution to the previously described formalism to find the 
absorbed dose to TLD.   
 
2.7.2 Film Dosimetry 
The radiochromic film measured the relative dose distributions.  The optical 
density of the film changes as a function of the dose received (due to a radiation induced 
polymerization within the active layer of the film). The film was calibrated according to 
RPC protocol.  A piece of film from the batch being utilized for the irradiation trials was 
cut into 3 cm by 3 cm squares.  These calibration films were placed under 1.5 cm of solid 
water with a further 9 cm of solid water as backscatter material.  The calibration films 
were then irradiated progressively from 50 monitor units to 1350 monitor units at a field 
size of 35 cm by 35 cm. This process was repeated three times. 
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The calibration films were scanned using the RPC’s film scanner, a CCD100 
Microdensitometer manufactured by the Photoelectron Corporation (North Billerica, 
MA).  The scanned films were exported as 32 bit .FIT files. 
The films were analyzed in ImageJ.  ImageJ is open source image analysis 
software developed by Wayne Rasband of the Research Services Branch of the NIH 
(Bethesda, MD). At each irradiation level, the mean optical density of the calibration film 
was measured.  The mean optical density was averaged across the three trials at each 
irradiation level.  The MUs delivered were converted to dose at the film depth by 
multiplying by the output factor at a 35 cm x 35 cm field size.  The film was at Dmax for 
the unit used, so no percent depth dose correction was needed.   
OD vs. Dose
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Figure 2.13: The dose response curve for the batch of Gafchromic EBT film utilized in 
this study; the chart plots the optical density against the dose.  
 
  
 
 32 
The function to calculate the dose from a measured optical density was calculated 
by inverting the data, and fitting a cubic function to the dose vs. OD curve, per RPC 
protocol.  The function calculated was as follows, with an R2 of .99: 
ODODODODDose *92.596.1438.29)( 23 +!"!=  
This dose response curve, shown in figure 2.13, was not used for absolute 
dosimetry; rather, it was used to measure the relative dose distribution.  The measured 
distributions were corrected by the measured TLD dose. 
 
2.7.3 Radiochromic Film Data Collection and Calibration to TLD 
Using the CCD100 film scanner, the film results from each phantom irradiation 
trial were converted into .FIT files, which contained a 512 by 512 array of the OD values.  
These files were read into MATLAB and were converted to dose (cGy) using the cubic 
fit from the dose response curve.  These values were then converted to 16 bit .TIF image 
files, with each pixel value in cGy.  Thus, the minimal step was 1 cGy, and the typical 
range recorded on the film was up to 1400 cGy.   
The film was then corrected to the measured TLD dose.  For each trial, there were 
four TLD measurements: Anterior/Superior, Anterior/Inferior, Posterior/Superior, and 
Posterior/Inferior. On the axial film, the mean doses at the two small circular localities 
where the TLDs abut the film were measured.  The ratio of the TLD dose to the film dose 
was calculated (at each location). The average of these ratios was calculated.  The film 
response was then multiplied by this ratio.  For the sagittal films, the same principle was 
used, but the mean was taken of a rectangular region running the length of the TLDs.  
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Figures 2.14 and 2.15 show the position of the TLDs relative to the calibration areas on 
the film. 
After the conversion to dose and the correction to the TLD dose measurement, the 
film was registered to the planned dose distribution for gamma analysis.   
 
 
Figure 2.14:  An illustration of the calibration points of the film relative to the TLDs for 
the axial plane. 
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Figure 2.15: An illustration of the calibration points of the film relative to the TLDs for 
the sagittal plane. 
 
2.7.4 Exporting Dose Planes from the TPS 
The ‘dose plane’ functionality within the Pinnacle TPS allows the user to sample 
an arbitrary 2-D distribution from the dose volume.  The physical film planes were 
visible on the CT image in the planning interface of the Pinnacle software, which allowed 
for an accurate selection of the correct plane for comparison.  After calculation of the 
dose distributions on a 2 x 2 x 2 mm3 dose grid, the dose was interpolated to 1 x 1 mm2 
pixels. These planes were exported from Pinnacle, and reformatted into 16 bit .TIF 
images, with each pixel value in cGy. 
 
2.7.5 Processing and Registration of Measured Data 
The pin pricks on the film provided the registration points to the planned dose.  
The pin pricks were visible on the 16-bit TIF film images.  However, the pin prick 
locations had to be added to the 16-bit TIF planned dose distributions; this was 
accomplished through an overlaying process.  The planned dose distributions, in a given 
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plane, were collimated to a known size.  The CT image was then collimated to the same 
size.  The CT image was overlaid onto the dose distribution, and the pin-prick locations 
were ‘burned’ (by changing the dose value at those points) into the planned distribution.  
This process was conducted for each planned dose distribution.  
Both the planned and measured distributions then had registration marks.  
However, there were differences in scaling and rotation between the images.  To address 
this, the coordinates of the pin pricks on the measured and planned distributions were 
found in ImageJ.  Then, image processing functionalities within MATLAB were used to 
calculate a transformation matrix between these sets of points.  The underlying distortion 
between the images were rotation and scaling, so a ‘linear conformal’ transformation 
matrix was calculated.  For scaling the measured dose distribution, a bilinear 
interpolation was utilized, per the procedure described by Childress et al. for conducting 
gamma analyses (Childress 2005).  Also, a smoothing median filter was applied to the 
measured distribution to reduce noise, per RPC protocol (Davidson 2006). The 
transformation matrix was applied to the measured dose distribution.  The result is a 
smoothed image scaled and rotated for an exact pinprick overlay to the planned 
distribution; this process downsampled the measured distribution to meet the resolution 
constraint of the planned dose distribution. This process, shown in Figure 2.16 was 
conducted for each individual piece of film; one axial film per trial, and two sagittal films 
per trial.  
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(1)     (2)   (3)    (4)   
Figure 2.16:  Data processing: (1) Raw OD data for one of the axial films from an 
irradiation trial.  (2) OD data processed by the dose response curve and smoothed with a 
median filter.  (3) The resultant dose distribution downsampled with bilinear 
interpolation and rotated to match the pin-prick locations of the planned distribution, 
shown in (4), with the pin locations ‘burned’ onto the image. 
 
2.9 Data Analysis: Gamma calculations, Isodose Planes and Profiles 
Once the films were registered, the data were then read into DoseLab, publicly 
available software for routine analysis of various dose distributions, created by Nathan 
Childress (Childress 2005).  The software was used for gamma calculations between 
planned and measured distributions.  Also, the software allowed for other qualitative 
assessments of the distributions.  Along with each of the gamma calculations, the 
following assessments were included: isodose overlays, dose profiles, and point dose 
comparisons.  These types of assessments are utilized by the RPC  for dose comparison in 
a variety of IMRT phantom studies  (Davidson 2006) (Molineu 2005).  For the dose 
profiles, the 5% dose difference and 3 mm DTA criteria were built onto the measured 
film profiles by implementing the gamma calculation in one dimension in a Microsoft 
Excel spreadsheet (Low 1998). 
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2.9.1 Gamma Analysis 
Gamma analysis has become a useful tool for routine IMRT quality assurance in 
clinics. Gamma analysis takes into account both distance-to-agreement (DTA) and dose 
difference in comparing planar dose distributions.  Gamma analysis takes advantage of 
the complementary sensitivities of DTA and dose difference, which are sensitive to low 
and high dose gradients, respectively. 
For two registered planar dose distributions, gamma analysis calculates the dose 
difference and DTA for each pixel as components of a vector normalized to the criteria of 
interest; if the magnitude of that vector exceeds 1, then that pixel fails the gamma 
analysis at the defined criteria (Low 1998). 
In Fig. 1, (rc, Dc) is a point on the calculated dose distribution (from treatment 
planning software), and (rr, Dr) is a point on the reference dose distribution (measured 
from the film plane). The symbols 
M
d!  and 
M
D!  are user defined tolerances for 
distance-to-agreement and dose difference, respectively.  
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Figure 2.17: Geometric relation of points used for a 2-D gamma calculation in assessing 
the reference and calculated distributions.  The x and y axes denote the spatial location 
of dose, and D denotes the dose axis, and (rc, Dc) denotes and arbitrary calculated dose 
value and location.   
 
The ellipsoid is defined on the reference distribution by the selected tolerances for 
M
d!  
and 
M
D! .  The calculated distribution is queried for the minimum gamma 
value, ),(
ccr
Dr! : 
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where D! and r! are defined as follows: 
rc
DDD !="  
rc
rrr !="  
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The!  value for a point on the reference distribution is the smallest value of 
),(
ccr
Dr! calculated.  If the!  value is less than or equal to one, that point passes the 
criteria (Low 1998). The percentage of passing points across a distribution is used as a 
proxy for how well the planned and measured distributions accord.  
 
2.9.2 Criteria Utilized 
 At what level should the tolerance for acceptable agreement between dose 
distributions be defined? For daily IMRT quality assurance regimens, a variety of 
tolerances are utilized in different clinics. For daily IMRT QA, M.D. Anderson utilizes a 
5% dose difference and 3 mm distance to agreement; a dose distribution assessment fails 
if less than 80% of the pixels pass the gamma analysis (Childress 2005). The RPC 
utilized a range from 5% / 3mm to 7% / 7mm in assessing agreement of radiation therapy 
fractions to its lung phantom.  Davidson et al. found greater than 95% pixel passing rates 
for the 5% / 3mm criteria when utilizing the collapsed-cone convolution dose algorithm 
with heterogeneity correction (Davidson 2006). For intensity modulated stereotactic body 
irradiations, UCLA conducts its quality assurance at a slightly tighter requirement, 3% / 
3mm (Slotman 2006).  The 3% / 3mm criteria were described as ‘quite stringent’ by the 
authors, and that small areas of disagreement are expected in a gamma analysis. 
In this project, the dose agreement criteria were the 5% / 3mm criteria utilized by 
Davidson et al.  The threshold for acceptable agreement used was a 95% pixel passing 
rate across a given dose plane.  An assessment at tightened dose difference and DTA 
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criteria, 3% / 2mm, was conducted as well; these tighter criteria addressed the demand for 
high geometric and dosimetric accuracy for a radiosurgical procedure.   
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Chapter 3 Results and Discussion 
3.1 Introduction 
The following sections detail each of the parameters tested for each of the 
irradiation plans: TLD measurements, dose profiles, isodose curves, and gamma analyses. 
In each section, the results of each treatment plan are presented in this order: four-field 
box, conformal, IMRT plan #1, and IMRT plan #2.  The four-field box irradiation had a 
simple geometry, and was used to establish a base line agreement for the non-modulated 
irradiation.  Next, the conformal irradiation was assessed; this plan had no modulation, 
but had increased complexity in beam geometry.  The four-field and conformal 
irradiations were not clinically feasible plans.  Next, IMRT plan #1 was assessed.  IMRT 
plan #1 did not meet the dose constraint requirements set forth by RTOG Protocol 0631.  
Also, this plan was administered incorrectly (with an approximately 2.5 mm shift from 
isocenter).  These results are presented to demonstrate how a misadministration appears 
in the analysis.  According to Andrea Molineu, an RPC physicist, about 15% of 
institutional failures in irradiating RPC phantoms are attributed to improper localizations, 
so the data from the IMRT plan #1 could help establish how an improper localization 
appears in the spine phantom.  Finally, IMRT plan #2 was analyzed.  IMRT #2 is an 
optimized plan and satisfied the clinical guidelines set forth in RTOG Protocol 0631.  
 
3.2 Qualitative Assessment of Anatomic Utility 
 There is no ‘perfect’ spinal tumor patient on which to base a phantom model; 
these tumors present in a wide range of sizes and anatomical locations. Institutions have 
utilized a variety of solutions for spine phantoms in spinal radiosurgery quality assurance.  
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Yin et al. utilized a Rando®  phantom (with simulated bone and lungs)  loaded with 
radiochromic film and an ion chamber for validation study of its spinal radiosurgery 
treatments (Yin 2002).  Medin et al. remapped treatment plans onto a CIRS thorax 
phantom (with simulated lungs) for patient specific quality assurance (Medin 2006).  The 
spine phantom studied here was designed with the unique needs of the RPC in mind; 
compromises were necessary to produce a phantom that is durable, water-filled, 
anatomically simple and relatively inexpensive to produce. Thus, anatomical features 
were approximated with geometric shapes.  A few other considerations were made for the 
spine phantom to be a representative spinal tumor case and a useful tool for the RPC: 
location, depth, and size of the target volume. 
Among 30 patients with spinal metastases treated by Dodd et al., the most 
frequent disease site was the thoracic vertebral body, which is where the target volume 
for the spine phantom is located (Dodd 2008).   
Patients with spinal metastases at the University of Pittsburgh Medical Center 
(Pittsburgh, PA) and Henry Ford Hospital (Detroit, MI) have their entire vertebral body 
and pedicles of the involved site delineated as the target volume (Ryu 2009).  In the spine 
phantom, the design of the target volume shape approximated a vertebral body with 
pedicles.  
The depth and size of the target volume (the vertebral body and pedicles) in the 
spine phantom should be close to that of a patient with a chest of similar breadth.  CT 
scans of a male M.D. Anderson patient were selected for comparison; this patient had a 
chest breadth similar to that of the spine phantom  A side-by-side comparison between 
the spine phantom and this patient demonstrated similarities in the proportion of the 
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phantom anatomy to that of the patient.  The comparison relied primarily on an axial 
view of the patient at the level of the heart, where the pedicles clearly define the spinal 
canal.   
 
 
Distance Comparison Distance (cm) 
Anatomy Measured: Patient Phantom 
Left to Right 38.2 36.3 
Anterior to Posterior 29.1 25 
Posterior to Anterior of Spinal Canal 6.8 6.7 
Posterior to Anterior of Vertebral Body 9.7 9.1 
Diameter Spinal Canal 2.0 1.5 
Thickness of Vertebral Body (not shown) 3.4 5.0 
 
Figure 3.1:  A comparison of important anatomical distances between a male patient and 
the spine phantom.   
 
The table in Figure 3.1 shows a close agreement for critical distances between the 
patient and the spine phantom.  The depth of the tumor, the size of the spinal canal, and 
the size of the treatment area were similar in scale for the phantom and the patient.  The 
thickness of the target volume of the spine phantom was slightly more than that of the 
vertebral body of the patient.   
Another important aspect of the spine phantom is the relation of the tumor to the 
spinal canal.  RTOG 0631 does not allow patients to enter the protocol when a lesion is 
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closer than 3 mm to the spinal cord (RTOG 2009).  In the phantom, the shortest distance 
between the spinal canal and the target volume was approximately 7 mm.   
The target volume in the spine phantom was measured to be 41.5 cm3.  After 500 
cases at their institution, Gerszten et al. found an average tumor volume of 46 cm3, with a 
range of volumes from 0.2 cm3 to 264 cm3.  The tumor volume for the spine phantom is 
near the average case, appropriate as a representative case (Gerszten 2007). 
 
3.3 TLD Measurements 
 Tables 3.1-3.4 and figures 3.2-3.5 show the absolute dose measurements at each 
of the TLD locations within the target volume.  They were labeled as Anterior/Superior, 
Anterior/Inferior, Posterior/Superior, Posterior/Inferior; the relative locations are shown 
in Figure 2.4 in the Methods and Materials section.  In each TLD capsule were two 
separate aliquots of powder.  Each of these aliquots contributed a single measurement.  
Because of the close spatial proximity of these aliquots, they were grouped together.  
Thus, over three irradiations, each TLD location had 6 samples.  The planned dose to 
each point was calculated by measuring the average dose to the TLD contour in the TPS.  
The coefficient of variance was also calculated for each TLD location, so that the relative 
spread could be compared between points.  
 
3.3.1 Four-Field Box: TLD Results 
Table 3.1 shows the TLD results from the four-field box irradiation.  
 
 
4-Field Box      
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Table 3.1:  The absorbed dose to TLD at each position for the Four- Field Box 
irradiation.  The sample standard deviation and COV (%) was calculated at each point.  
The ratio of planned/measured was calculated for each TLD position. 
 
 In order to show the agreement between the measured and planned dose for each 
TLD location, Figure 3.1 shows the ratio of the planned to measured data with error bars 
indicating the 95% confidence interval at each location (n = 6 measurements) for the 
four-field box irradiation. 
 
Box Irradiation: TLD Results
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Figure 3.2:  The ratio of the planned to measured dose for the Four-Field Box 
irradiation with 95% C.I.’s for n=6 measurements.  Each gridline indicates a 1% 
change, and the gridline at a ratio of 1 is in bold.   
 
TLD Position: 
Mean Dose 
(cGy) Sample S.D. COV (%) 
Planned Dose 
(cGy) 
Planned/ 
Measured 
Superior/Anterior 900.8 7.3 0.8 898.0 0.997 
Inferior/Anterior 904.0 6.6 0.7 906.3 1.003 
Superior/Posterior 921.4 9.7 1.1 908.3 0.990 
Inferior/Posterior 909.6 13.0 1.4 908.8 0.999 
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Figure 3.1 demonstrates that the TLD measurements agree well with the planned dose.  
The mean dose measured is slightly more than 1% off at the Superior/Posterior location.  
At each location, the null hypothesis that Planned/Measured = 1 was tested at the 5% 
confidence level.  At each TLD location, the null hypothesis was not rejected.    
 
3.3.2 Conformal Irradiation: TLD Results 
 Table 3.2 shows the TLD results from the conformal irradiation with the standard 
deviation, COV (%), and the ratio of planned to measured dose. 
 
Conformal      
TLD Position: 
Mean Dose 
(cGy) Sample S.D. COV (%) 
Planned Dose 
(cGy) 
Planned/ 
Measured 
Superior/Anterior 919.3 6.1 0.7 920 1.001 
Inferior/Anterior 928.9 7.5 0.8 927.2 0.998 
Superior/Posterior 959.1 9.0 0.9 960.1 1.001 
Inferior/Posterior 957.3 10.6 1.1 961.8 1.005 
Table 3.2:  The absorbed dose to TLD at each position for the Conformal irradiation.  
The sample standard deviation and COV (%) was calculated at each point.  The ratio of 
planned/measured was calculated for each TLD position.   
 
 The following figure shows the ratio of planned to measured dose at each TLD 
location for the conformal irradiation. The 95% C.I.’s are shown for each point.   
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Conformal Irradiation: TLD Results
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Figure 3.3:  The ratio of the planned to measured dose with 95% C.I.’s for n=6 
measurements.  Each gridline indicates a 1% change, and the gridline at a ratio of 1 is in 
bold. 
Figure 3.2 shows good agreement between the measured dose and the planned 
dose for the conformal irradiation.  At each location, the null hypothesis that 
Planned/Measured = 1 was tested at the 5% confidence level.  At each TLD location, the 
null hypothesis was not rejected.    
 
3.3.3 IMRT #1: TLD Results 
The following table shows the TLD results from the conformal irradiation with 
the standard deviation, COV, and the ratio of planned to measured dose. 
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IMRT #1      
TLD Position: 
Mean Dose 
(cGy) Sample S.D. COV (%) 
Planned Dose 
(cGy) 
Planned/ 
Measured 
Superior/Anterior 830 10.5 1.3 863 1.040 
Inferior/Anterior 807.2 4.7 0.6 857.9 1.063 
Superior/Posterior 795.7 8.0 1 843.6 1.060 
Inferior/Posterior 787.1 17.2 2.1 833.2 1.059 
Table 3.3:  The absorbed dose to TLD at each position for each trial for the IMRT #1 
irradiation.  The sample standard deviation and COV (%) was calculated at each point.  
The ratio of planned/measured was calculated for each TLD position. 
  
 The following figure shows the ratio of planned to measured dose at each TLD 
location for the conformal irradiation. The 95% C.I.’s are shown for each point.   
 
IMRT #1 Irradiation: TLD Results
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Figure 3.4:  The ratio of the planned to measured dose with 95% C.I.’s for n=6 
measurements.  Each gridline indicates a 1% change, and the gridline at a ratio of 1 is in 
bold. 
 
Figure 3.3 shows poor agreement between the mean dose to TLD and the planned dose 
for the IMRT plan #1 irradiation.  However, this trial was misadministered (was 
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incorrectly localized by approximately 2.5 mm), and a difference in the measured and 
planned was expected, especially due to the large dose gradients within the target 
volume.  The incorrect positioning was more apparent in the isodose distribution of these 
irradiations, shown in section 3.4.3.  The method used to detect and measure the 
misadministration is also discussed in section 3.4.3. At each location, the null hypothesis 
that Planned/Measured = 1 was tested at the 5% confidence level.  At each TLD location, 
the null hypothesis was rejected.  
 
3.3.4 IMRT #2: TLD Results 
The following table shows the TLD results from the conformal irradiation with the 
standard deviation, COV, and the ratio of planned to measured dose. 
IMRT #2      
TLD Position: 
Mean Dose 
(cGy) Sample S.D. COV (%) 
Planned Dose 
(cGy) Planned/Measured 
Superior/Anterior 1059.1 14.0 1.3 1054 0.995 
Inferior/Anterior 1050.7 20.0 1.9 1070 1.018 
Superior/Posterior 1081 33.2 3.1 1083 1.002 
Inferior/Posterior 1095.6 27.4 2.5 1092 0.997 
Table 3.4:  The absorbed dose to TLD at each position for each trial for the IMRT #2 
irradiation.  The sample standard deviation and COV (%) was calculated at each point.  
The ratio of planned/measured was calculated for each TLD position.   
 
The following figure shows the ratio of planned to measured dose at each TLD location 
for the conformal irradiation. The 95% C.I.’s are shown for each point.  
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IMRT #2 Irradiation: TLD Results
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Figure 3.5:  The ratio of the planned to measured dose with 95% C.I.’s for n=6 
measurements.  Each gridline indicates a 1% change, and the gridline at a ratio of 1 is 
highlighted.  
 
Figure 3.4 shows good agreement between the mean dose to TLD and the planned dose 
for the IMRT plan #2 irradiation.  However, at some locations, the 95% CI exceeded +/- 
5%.   At each location, the null hypothesis that Planned/Measured = 1 was tested at the 
5% confidence level.  At each TLD location, the null hypothesis was not rejected. 
However, the 95% CI’s were larger for the IMRT #2 irradiation than for the four-field 
box and conformal irradiations.  This was likely due to the high dose gradients within the 
target volume and across the TLD themselves.  
 The mean dose measurement at each TLD location for the four-field box, 
conformal, and IMRT #2 plans were all within 2% of the planned dose.  These results are 
consistent with TLD results of the RPC study by Davidson et al. that utilized a Pinnacle 
dose engine to predict dose in a lung phantom.  In Davidson et al.’s study, the TLD dose 
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measurements were within 2% of the predicted measurement in three trials (Davidson 
2006).  These results are also well within the 5% dose difference criteria applied in the 
gamma analysis.  These results demonstrated that, for a well-localized irradiation, the 
Pinnacle collapsed-cone convolution superposition dose engine accurately predicted the 
dose measured with TLD.  One potential issue, however, is the steep dose gradients 
across the TLD; the size of the 95% confidence intervals indicate that there is greater 
uncertainty in intensity modulated irradiations such as IMRT plans #1 and #2 than in the 
four-field box and conformal irradiations.  The standard deviation of the dose to the TLD 
contour, measured in the TPS, reveals a greater variation of dose across the TLD in the 
intensity modulated plans.  Whereas the coefficients of variance of the mean dose to the 
TLD for the four field box and conformal plans are below 1%, the coefficients of 
variance of the mean dose to the TLD for the IMRT plans #1 and #2 are between 2% and 
3%.  This observation agrees with the greater uncertainties seen in the measured TLD 
doses of the intensity modulated plans.  
 
3.4 Axial Profile and Isodose Distributions 
Each sagittal and axial film plane was corrected to the TLD dose according to the 
procedure described Section 2.8.3.  The planned and measured dose distributions were 
compared visually with isodose distributions and axial profiles.  These comparisons 
provided context for the gamma analyses. The isodose distributions allowed for 
inspection of the agreement of selected dose contours across the entire film plane.  
Although only one dimension is assessed with the dose profile, the 5% / 3 mm was 
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displayed alongside.  With the criteria displayed on the chart, the agreement of the 
planned and measured dose profiles was assessed relative to the 5% / 3 mm criteria.   
For each irradiation, the axial dose profile was taken through a registration 
pinprick, as shown in Fig 3.6.  For each measured dose profile, the three trials per 
irradiation technique were averaged. 
 
Figure 3.6:  The axial dose profile location: for each irradiation technique, the dose 
profiles were taken along the line indicated in the figure.  The profiles were taken 
through the pinprick in order to register each of the film series together.  For each 
irradiation technique, the 3 trials were averaged. 
 
3.4.1 Four-Field Box Plan: Isodose Distributions and Axial Dose Profile 
Figure 3.7 shows the isodose distributions in the axial and sagittal planes of the 
first trial of the four-field box irradiation.  The isodose distributions for the second and 
third trials are in the appendix. 
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Figure 3.7: Isodose distributions for the axial and sagittal planes of the Four-field Box 
irradiation. The figure shows, from left to right, the axial, inferior sagittal, and superior 
sagittal planes.  Due to small deviations in the cropping and registration, the scale is not 
the same for each portion of the figure. 
 
Figure 3.7 visually demonstrates the close agreement of the selected isodose lines of the 
planned and measured dose distributions for the first trial of the four-field box irradiation.  
Because of some slight differences in registration of the superior and inferior portions of 
the sagittal film, there is some overlap of the display.   
 Figure 3.8 shows the mean axial dose profile and the planned dose profile. 
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Box Plan: Axial Dose Profile
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Figure 3.8:  Axial dose profile: four-field box irradiation.  The x-axis is the distance from 
the top of the cropped axial plane.  The film dose profile is the average of the three trials.  
The 5% / 3 mm gamma criteria are represented as the dotted lines above and below the 
film dose profile. The planned tumor volume and spinal cord are also shown on the 
profiles. 
 
Visual inspection of the graph of the planned to measured dose shows good agreement 
along the profile; the planned dose did not move outside of the allowed tolerance along 
the profile.  However, the planned dose does deviate from the measured dose at the 
posterior surface of the PTV, but not by more than 5%. 
 For the four-field box irradiation, the planned and measured dose distributions 
agree across the film plane.   
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3.4.2 Conformal Plan: Isodose Distributions and Axial Dose Profiles 
Figure 3.9 shows the axial and sagittal isodose distributions for the first trial of 
the conformal irradiation. 
 
  
Figure 3.9: Isodose distributions for the axial and sagittal planes of the conformal 
irradiation. The figure shows, from left to right, the axial, inferior sagittal, and superior 
sagittal planes.  Due to small deviations in the cropping and registration, the scale is not 
the same for each portion of the figure.  
 
Figure 3.9 visually demonstrates the close agreement of the planned and measured 
dose distribution for the conformal irradiation.  Small deviations of the planned dose 
from the measured are perceptible across the sagittal and axial film planes, but overall, 
there is a close agreement.  Figure 3.10 is the axial dose profile for the conformal plan. 
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Conformal Plan: Axial Dose Profile
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Figure 3.10:  Axial dose profile: Conformal irradiation.  The x-axis is the distance from 
the top of the cropped axial plane.  The film dose profile is the average of the three trials. 
The 5% / 3 mm gamma criteria are represented as the dotted lines above and below the 
film dose profile. The planned tumor volume and spinal cord are also shown on the 
profiles. 
 
In Figure 3.9, the axial dose profile demonstrates good agreement across the film plane.  
The planned dose is very close to the mean film dose (n=3 trials), and does not approach 
or exceed the 5% / 3 mm criteria bounding the measured dose.   
 
3.4.3 IMRT #1 Plan: Isodose distributions and axial dose profile 
Figure 3.11 shows the isodose distributions for the second trial of the IMRT #1 
irradiation.  The second trial is shown because the axial film of the first trial was over 
exposed (the film may have been exposed to fluorescent light).   
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Figure 3.11: Isodose distributions for the axial and sagittal planes of the IMRT #1 
irradiation. The figure shows, from left to right, the axial, inferior sagittal, and superior 
sagittal planes.  Due to small deviations in the cropping and registration, the scale is not 
the same for each portion of the figure.  
 
Figure 3.11 illustrates the result of the localization error during irradiation.  The 
planned and measured distributions have similar forms, but the measured distribution is 
shifted relative to the planned distributions in 3 aspects: left, inferiorly, and posteriorly.  
The shift is approximately 2.5 mm in magnitude. This shift magnitude was calculated 
using the autocorrelation function in the DoseLab software; the software calculates a best 
fit between the planned and measured dose distributions, and the spatial shift from the 
pinprick registration to the calculated registration was measured.  This error was 
expected, as the phantom was localized using external markers placed during simulation.  
Despite the localization error, the IMRT plan #1 data set was included to showcase how 
the error can be visualized using these modes of data presentation. 
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 Figure 3.12 is the axial dose profile for the IMRT #1 irradiation.  
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Figure 3.12:  Axial dose profile: IMRT #1 irradiation.  The x-axis is the distance from 
the top of the cropped axial plane.  The film dose profile is the average of the two  trials. 
The 5% / 3 mm gamma criteria are represented as the dotted lines above and below the 
film dose profile. The planned tumor volume and spinal cord are also shown on the 
profiles. 
 
 Again, the shift in the measured distribution relative to the planned distribution is 
apparent; while the profiles maintain the same form, the planned distribution nearly 
exceeds the dose difference and distance-to-agreement criteria along the profile, due to 
the localization error. 
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3.4.4 IMRT #2 Plan: Isodose distributions and axial dose profile 
 Figure 3.13 is the isodose distributions for the first trial of the IMRT plan #2 
irradiation.  The isodose distributions for the other trials are in the Appendix.     
  
Figure 3.13: Isodose distributions for the axial and sagittal planes of the IMRT #2 
irradiation. The figure shows, from left to right, the axial, inferior sagittal, and superior 
sagittal planes.  Due to small deviations in the cropping and registration, the scale is not 
the same for each portion of the figure. 
 
The isodose distributions for this trial demonstrate agreement between the planned and 
measured dose distributions.  In the axial plane, the region of highest dose displayed 
(1000 cGy) is slightly smaller than the planned region.  When scanning vertically down 
the sagittal and axial planes, the planned and measured isodose lines accord well along 
the steep dose gradient.  The accordance along the steep dose gradient is demonstrated 
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with the axial dose profile, shown in Figure 3.14. 
IMRT #2: Axial Dose Profile
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Figure 3.14:  Axial dose profile: IMRT #2 irradiation.  The x-axis is the distance from 
the top of the cropped axial plane.  The film dose profile is the average of the three trials. 
The 5% / 3 mm gamma criteria are represented as the dotted lines above and below the 
film dose profile. The planned tumor volume and spinal cord are also shown on the 
profiles. 
 
In Figure 3.14 the measured dose agrees well with the planned dose. The planned 
dose does not deviate much from the measured dose, and along the entire profile does not 
approach the bounding criteria.  However, above 1000 cGy, the measured dose is slightly 
lower than the planned dose.  This discrepancy is also apparent in the isodose 
distributions at 1000 cGy.  These discrepancies may be attributable to the dose level 
selected for the prescriptions.  The maximum dose in the PTV from IMRT plan #2 is 
significantly higher than the prescription dose of 800 cGy.  Further scaling down the 
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prescription dose could allow for the film to capture the higher dose levels in a more 
useful portion of the dynamic range of the film where there is a greater change in the 
optical density per change in the dose. 
 
3.5 Gamma Analysis 
The gamma analyses were performed for the sagittal and axial film planes to test 
the accordance of the planned and measured distributions.  The gamma analysis process 
is described in the Methods and Materials section; this project used the implementation in 
the publicly available DoseLab software.   For each ‘gamma map’ presented in this paper, 
pixels on the gamma map passing the 5% / 3 mm criteria (gamma value less than 1) are 
shown in grayscale, while pixels with a value greater than or equal to 1 are color mapped 
from yellow to red, to clearly indicate where the gamma maps begins to fail to meet the 
criteria (Note: gamma values of 1 are considered passing, but are color mapped to 
enhance visualization of regions of failure).  The axial and sagittal gamma maps for one 
trial of each irradiation are presented here (corresponding to the isodose distributions 
presented previously); the gamma maps for the remaining trials are in the Appendix.  The 
following figures are the gamma maps for single trials for the four-field box, conformal, 
IMRT plan #1, and IMRT plan #2 irradiations. 
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Figure 3.15: Gamma analysis maps of the axial and sagittal planes for the first trial of 
the Four-field Box irradiation. The x and y axes are the pixel locations. The gamma value 
at each point is color coded according to the bar on the right of the figure. Due to small 
deviations in the image cropping and registration, the scale is not exactly the same for 
each portion of the figure. 
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Figure 3.16: Gamma analysis maps of the axial and sagittal planes for the first trial of 
the conformal irradiation. The x and y axes are the pixel locations. The gamma value at 
each point is color coded according to the bar on the right of the figure. Due to small 
deviations in the image cropping and registration, the scale is not exactly the same for 
each portion of the figure. 
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Figure 3.17: Gamma analysis maps of the axial and sagittal planes for the second trial of 
the IMRT #1 irradiation. The x and y axes are the pixel locations. The gamma value at 
each point is color coded according to the bar on the right of the figure. Due to small 
deviations in the image cropping and registration, the scale is not exactly the same for 
each portion of the figure. 
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Figure 3.18: Gamma analysis maps of the axial and sagittal planes for the first trial of 
the IMRT #2 irradiation. The x and y axes are the pixel locations. The gamma value at 
each point is color coded according to the bar on the right of the figure. Due to small 
deviations in the image cropping and registration, the scale is not exactly the same for 
each portion of the figure. 
 
Figures 3.15 – 3.18 are the gamma maps for single trials for the four-field box, 
conformal, IMRT #1, and IMRT #2 plans at the gamma criteria of 5% / 3 mm. The only 
failure patterns of note occurred on the IMRT plan #1 irradiation, when the irradiation 
was not well localized.  On the IMRT plan #2 gamma maps, there were small regions of 
failure near the center of the high dose region on the axial plane; these regions were also 
apparent in the isodose distributions and axial dose profiles. 
 The following table shows the percentage of pixels, in each plane, that pass the 
criteria for each irradiation.   Also included are the percentages of passing pixels at 
tighter gamma criteria.  The tighter criteria are included because of the near perfect 
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agreement at the 5% / 3mm level for the four-field box, conformal, and IMRT plan #2 
irradiations. 
Mean Percentage of Passing Pixels    
Plan: Plane: 5%/3mm 5%/2mm 3%/2mm Sample Size 
Box Axial 99.6 99.5 95.6 3 
  Sagittal 99.3 99.3 95.4 3 
3-D Conformal Axial 99.4 99.3 97.9 3 
  Sagittal 99.8 99.8 97.1 3 
IMRT #1 Axial 93.3 80.2 63.3 2 
  Sagittal 91.4 74.1 61.3 3 
IMRT #2 Axial 99.6 98.7 94.4 3 
  Sagittal 100 99.9 98.5 3 
Table 3.5: The mean percentage of pixels passing the gamma criteria for each dose plane 
in each irradiation.  Increasingly tighter criteria are shown in the table. Only 2 samples 
were available for the axial plane of the IMRT plan #1 due to an overexposure of one 
film to fluorescent light.    
 
The threshold for good agreement across a dose plane is customarily that 95% of the 
pixels pass the selected criteria.  The table indicates that for the three well localized plans 
(excluding IMRT plan #1, which was not well localized), there is nearly perfect 
agreement at the 5% / 3 mm level.  The irradiation with a 2.5 mm shift, IMRT plan #1, 
shows slightly worse agreement, but is still above 90% agreement across the trials.  When 
subjected to a distance criterion tighter than the positioning error (the positioning error 
was approximately 2.5 mm), the pixel passing percentage dropped precipitously, while 
the other trials maintained near perfect agreement.  This finding suggests that the RPC 
may utilize a tighter distance to agreement criterion to better capture small positioning 
errors committed by institutions irradiating the spine phantom.  
 The results of the gamma analysis were consistent with a previous RPC study by 
Davidson et al., which found greater than 95% agreement across the gamma analysis 
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maps when using the Pinnacle dose engine to predict doses in a lung phantom (Davidson 
2006).   
 
Chapter 4 Conclusions and Future Work 
4.1 Conclusions 
The spine phantom is to be used to test institution’s ability to scan, plan, and 
administer a stereotactic radiosurgical treatment. The dosimetric utility of the spine 
phantom was tested using a variety of irradiation plans, from unmodulated beams to 
clinically applicable IMRT plans.  This project assessed the dosimetric agreement 
between the clinically utilized TPS at M.D. Anderson and the TLD/radiochromic film 
system implemented in the phantom.   
The anatomy of the spine phantom was determined to closely emulate that of a 
patient with a similar chest breadth.  The depth and size of the target volume and spinal 
canal were very similar to that of the sample patient, and the proximity of the spinal canal 
to the target volume did not exclude the spine phantom from RTOG 0631. 
Using established 2-D dose plane comparison techniques, the planned and 
measured dose distributions showed excellent agreement in the four-field box, conformal, 
and IMRT plan #2 irradiations.  The IMRT plan #1 irradiation did not pass the criteria set 
forth in this project, due to poor localization of the treatment isocenter during the 
treatment administration.  This irradiation was included for illustrative purposes of the 
failure patterns for a poor localization.   
 The isodose distributions and axial dose profiles were first utilized to assess the 
agreement between the planned and administered dose across the axial and sagittal film 
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planes.  For the four-field box, conformal, and IMRT plan #2 irradiations, the isodose 
distributions demonstrated agreement across the sagittal and axial film planes.  For the 
IMRT #2 distributions, there was some disagreement at the high dose levels.  This 
disagreement may warrant a revisiting of the film calibration at those higher dose levels, 
over 1000 cGy.   
 The results of the isodose distributions and dose profiles were consistent with 
studies conducted by the RPC for other anthropomorphic phantoms.  Specifically, the 
collapsed-cone convolution dose calculation algorithm accurately calculated the 
measured dose across inhomogeneities. This project demonstrated that this assumption 
can be extended to the new spine phantom when irradiating with intensity modulated 
radiosurgical plans with small margins.  
 The gamma distributions for the four-field box, conformal, and IMRT plan #2 
irradiations showed excellent agreement (> 95%) in the gamma analyses at the 5% / 3 
mm and 3% / 2 mm levels.  The IMRT #1 irradiation showed lower levels of agreement 
at both criteria; this was expected, as the spine phantom was shifted 2.5 mm from the 
planned isocenter.  The following chart summarizes the levels of agreement for the 
gamma maps for each irradiation:   
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Figure 4.1:  The mean percentage of pixels passing the gamma criteria for each 
anatomic plane for each irradiation type. 
This figure demonstrates the greater than 95% agreement across each gamma map for the 
four field box, conformal and IMRT plan #2 irradiations at the 5% / 3 mm level.  The 
tighter criteria also reflect excellent agreement for these irradiations.  Visual inspection of 
the gamma maps and isodose distributions of the IMRT plan #1 irradiation reveal a clear 
shift; however, the number of pixels passing criteria is greater than 90% at the 5% / 3mm 
level.  This reflects the relative laxity of that criterion; the 3% / 2mm criteria better 
capture the misadministration.  Thus, when selecting criteria, it is important to consider 
the types and levels of errors tolerated, especially when considering the accuracy 
necessary for spinal radiosurgery. The limiting accuracy of the localization process used 
in this study should also be considered.  The accuracy of the jaw positioning, per the 
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AAPM Task Group 142 report, is +/- 1 mm for each jaw (Klein 2009).  As both jaws are 
subject to this uncertainty, the localization uncertainty of the process used here is at least 
1 mm. 
This project demonstrated the dosimetric utility of the spine phantom for 
unmodulated and IMRT treatment plans for radiosurgical dose levels with proper 
localization.  This project confirmed that the phantom is useful for assessing institutions 
participating in spinal radiosurgery protocols.  The hypothesis, that the newly constructed 
spine phantom provided a useful model for planning intensity modulated radiosurgery for 
spinal tumors, and the collapsed-cone convolution dose algorithm accurately models the 
dose distributions measured via radiochromic film and TLD, was not rejected through 
testing in each specific aim of this research.   
 
4.2 Future Work 
This project applied to institutions that utilize conventional linear accelerators 
equipped with MLCs and planning systems that utilize a collapsed-cone convolution dose 
algorithm with heterogeneity correction, such as that implemented in the Pinnacle TPS.  
However, another technology used for external beam radiosurgery is the Cyberknife 
system, manufactured by Accuray (Sunnyvale, CA).  Cyberknife utilizes a linear 
accelerator mounted on an articulating robotic arm with circular apertures.  Cyberknife 
uses implanted gold fiducials and orthogonal kV imaging for localization.  Accuray has 
recently upgraded its treatment planning software, MultiPlan®, from a pencil beam based 
calculation to a Monte Carlo dose algorithm (Mardirossian 2009). The RPC has already 
adapted a spine phantom for use with Cyberknife by placing gold fiducials into the spinal 
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insert.  Future work may include generating plans in both versions of the Cyberknife 
treatment planning software, irradiating the spine phantom on a Cyberknife system, and 
using the criteria in this project to verify the dosimetric utility of the phantom for the 
Cyberknife system. 
The RPC is also implementing optically stimulated luminescent (OSL) dosimeters 
in the place of TLD for remote dosimetry. The RPC’s transition to OSL is ongoing, and 
the spinal insert could be adapted to Landauer’s (Glenwood, IL) NanoDot® OSL 
cartridges.   
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Figure 5.1: Isodose distributions for the axial and sagittal planes of the Four-Field Box 
irradiation, Trial 2. The figure shows, from left to right, the axial, inferior sagittal, and 
superior sagittal planes.  Due to small deviations in the cropping and registration, the scale 
is not the same for each portion of the figure.  
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Figure 5.2: Gamma analysis maps of the axial and sagittal planes for the Four-Field Box 
irradiation, Trial 2. The x and y axes are the pixel locations. The gamma value at each point 
is color coded according to the bar on the right of the figure.  
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Figure 5.3: Isodose distributions for the axial and sagittal planes of the Four-Field Box 
irradiation, Trial 3. The figure shows, from left to right, the axial, inferior sagittal, and 
superior sagittal planes.  Due to small deviations in the cropping and registration, the scale 
is not the same for each portion of the figure.  
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Figure 5.4: Gamma analysis maps of the axial and sagittal planes for the Four-Field Box 
irradiation, Trial 3. The x and y axes are the pixel locations. The gamma value at each point 
is color coded according to the bar on the right of the figure. 
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Figure 5.5: Isodose distributions for the axial and sagittal planes of the conformal 
irradiation, Trial 2.  The figure shows, from left to right, the axial, inferior sagittal, and 
superior sagittal planes.  Due to small deviations in the cropping and registration, the scale 
is not the same for each portion of the figure.  
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Figure 5.6: Gamma analysis maps of the axial and sagittal planes for the Conformal 
irradiation, Trial 2. The x and y axes are the pixel locations. The gamma value at each point 
is color coded according to the bar on the right of the figure. 
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Figure 5.7: Isodose distributions for the axial and sagittal planes of the Conformal 
irradiation, Trial 3. The figure shows, from left to right, the axial, inferior sagittal, and 
superior sagittal planes.  Due to small deviations in the cropping and registration, the scale 
is not the same for each portion of the figure.  
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Figure 5.8: Gamma analysis maps of the axial and sagittal planes for the Conformal 
irradiation, Trial 3. The x and y axes are the pixel locations. The gamma value at each point 
is color coded according to the bar on the right of the figure. 
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Figure 5.9: Isodose distribution of the sagittal plane of the IMRT #1 irradiation, Trial 1. The 
figure shows, from left to right, the inferior sagittal and superior sagittal planes.  Due to 
small deviations in the cropping and registration, the scale is not the same for each portion 
of the figure.  
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Figure 5.10: Gamma analysis map of the sagittal plane of the IMRT #1 irradiation, Trial 1. 
The x and y axes are the pixel locations. The gamma value at each point is color coded 
according to the bar on the right of the figure.  
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Figure 5.11: Isodose distributions for the axial and sagittal planes of the IMRT #1 
irradiation, Trial 3. The figure shows, from left to right, the axial, inferior sagittal, and 
superior sagittal planes.  Due to small deviations in the cropping and registration, the scale 
is not the same for each portion of the figure.  
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Figure 5.12: Gamma analysis maps of the axial and sagittal planes for the IMRT #1 
irradiation, Trial 3. The x and y axes are the pixel locations. The gamma value at each point 
is color coded according to the bar on the right of the figure.  
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Figure 5.13: Isodose distributions for the axial and sagittal planes of the IMRT #2 
irradiation, Trial 2. The figure shows, from left to right, the axial, inferior sagittal, and 
superior sagittal planes.  Due to small deviations in the cropping and registration, the scale 
is not the same for each portion of the figure.  
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Figure 5.14: Gamma analysis maps of the axial and sagittal planes for the IMRT #2 
irradiation, Trial 2. The x and y axes are the pixel locations. The gamma value at each point 
is color coded according to the bar on the right of the figure 
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Figure 5.15: Isodose distributions for the axial and sagittal planes of the IMRT #2 
irradiation, Trial 3.. The figure shows, from left to right, the axial, inferior sagittal, and 
superior sagittal planes.  Due to small deviations in the cropping and registration, the scale 
is not the same for each portion of the figure.  
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Figure 5.16: Gamma analysis maps of the axial and sagittal planes for the IMRT #2 
irradiation, Trial 3. The x and y axes are the pixel locations. The gamma value at each point 
is color coded according to the bar on the right of the figure. 
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